Stephen Chia
Impact in
- Cancer Research top 0.05%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 0.5%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
-
- Breast Cancer Treatment Studies 75
- Cancer Genomics and Diagnostics 13
- Oncology 51
- HER2/EGFR in Cancer Research 30
- Cancer survivorship and care 6
- Co-authors
- Torsten O. Nielsen (18 shared papers)Maggie C.U. Cheang (12 shared papers)Samuel C. Y. Leung (12 shared papers)Karen A. Gelmon (36 shared papers)Charles M. Perou (6 shared papers)David K. Voduc (3 shared papers)Chris D Bajdik (9 shared papers)Caroline H. Speers (18 shared papers)
- Journals
- Annals of Oncology (26 papers)Journal of Clinical Oncology (16 papers)Breast Cancer Research and Treatment (13 papers)Clinical Cancer Research (13 papers)The Lancet Oncology (9 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Stephen Chia
187 papers receiving 17.5k citations
Stephen Chia's Hit Papers
Peers
Comparison fields: 5 of 135
- Cancer Research 8.7k
- Oncology 4.4k
- Pulmonary and Respiratory Medicine 2.3k
- Pathology and Forensic Medicine 640
- Molecular Biology 2.3k
Countries citing papers authored by Stephen Chia
This map shows the geographic impact of Stephen Chia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Chia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Chia more than expected).
Fields of papers citing papers by Stephen Chia
This network shows the impact of papers produced by Stephen Chia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Chia. The network helps show where Stephen Chia may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen Chia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 194 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer Hit paper breakdown → | 2009 | 1783 |
| 2 | The clonal and mutational evolution spectrum of primary triple-negative breast cancers Hit paper breakdown → | 2012 | 1650 |
| 3 | Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype Hit paper breakdown → | 2008 | 1004 |
| 4 | Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA) Hit paper breakdown → | 2013 | 958 |
| 5 | 2014 | 495 | |
| 6 | 2017 | 469 | |
| 7 | 2016 | 461 | |
| 8 | 2005 | 460 | |
| 9 | Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2017 | 460 |
| 10 | Double-Blind, Randomized Placebo Controlled Trial of Fulvestrant Compared With Exemestane After Prior Nonsteroidal Aromatase Inhibitor Therapy in Postmenopausal Women With Hormone Receptor–Positive, Advanced Breast Cancer: Results From EFECT Hit paper breakdown → | 2008 | 419 |
| 11 | 2001 | 379 | |
| 12 | 2007 | 373 | |
| 13 | 2019 | 319 | |
| 14 | Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study Hit paper breakdown → | 2021 | 283 |
| 15 | 2016 | 270 | |
| 16 | 2012 | 257 | |
| 17 | 2008 | 250 | |
| 18 | 2009 | 234 | |
| 19 | 2001 | 216 | |
| 20 | 2017 | 212 |
About Stephen Chia
Stephen Chia is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Genetics and Cardiology and Cardiovascular Medicine, having authored 194 papers that have together received 18k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (75 papers), Advanced Breast Cancer Therapies (42 papers), HER2/EGFR in Cancer Research (30 papers), Cancer Genomics and Diagnostics (13 papers), BRCA gene mutations in cancer (7 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers), Chemotherapy-induced cardiotoxicity and mitigation (6 papers) and Cancer survivorship and care (6 papers). The work is most often cited by research in Cancer Research (8.7k citations), Oncology (4.4k citations), Pulmonary and Respiratory Medicine (2.3k citations), Pathology and Forensic Medicine (640 citations) and Molecular Biology (2.3k citations). Stephen Chia has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Torsten O. Nielsen, Maggie C.U. Cheang, Samuel C. Y. Leung, Karen A. Gelmon, Charles M. Perou, David K. Voduc, Chris D Bajdik, Caroline H. Speers, Dongxia Gao and Ivo A. Olivotto. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Breast Cancer Research and Treatment, Clinical Cancer Research and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.